Affordable Access

Publisher Website

Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist

Authors
Journal
Journal of Cardiovascular Ultrasound
1975-4612
Publisher
Korean Society of Echocardiography (KAMJE)
Publication Date
Volume
21
Issue
3
Identifiers
DOI: 10.4250/jcu.2013.21.3.140
Keywords
  • Case Report
Disciplines
  • Medicine

Abstract

The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who was able to successfully undergo percutaneous shunt closure following 1 year use of the oral endothelin receptor antagonist, bosentan.

There are no comments yet on this publication. Be the first to share your thoughts.